US2007037262A1PendingUtilityA1
Genes encoding genetic stability, gene expression and folding proteins
Est. expiryNov 5, 2021(expired)· nominal 20-yr term from priority
Inventors:Oskar ZelderMarkus PompejusHartwig SchröderBurkhard KrogerCorinna KlopproggeGregor Haberhauer
C07K 14/34C12N 9/00C12N 9/0006C12N 15/11C12P 13/08
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to novel nucleic acid molecules, to the use thereof for constructing genetically improved microorganisms and to methods for preparing fine chemicals, in particular amino acids, with the aid of said genetically improved microorganisms.
Claims
exact text as granted — not AI-modified1 . An isolated nucleic acid molecule selected from the group consisting of:
a) an isolated nucleic acid molecule coding for a polypeptide comprising the amino acid sequence referred to in Table 1/column 2, wherein the nucleic acid molecule encodes an amino acid residue at the position referred to in Table 1/column 4 of the same row that differs from the amino acid residue referred to in Table 1/column 5 of the same row, or a complement thereof; b) an isolated nucleic acid molecule comprising the nucleotide sequence referred to in Table 1/column 1, wherein the nucleic acid molecule comprises one or more nucleic acid modifications as compared to the nucleic acid molecule referred to in Table 1/column 1 such that the polypeptide encoded by the nucleic acid molecule has an amino acid residue at the position referred to in Table 1/column 4 of the same row that differs from the amino acid residue referred to in Table 1/column 5 of the same row, or a complement thereof; and c) an isolated nucleic acid molecule comprising the nucleotide sequence referred to in Table 1/column 1, wherein the nucleic acid molecule comprises one or more modifications at the nucleotide residues encoding the amino acid residue at the position referred to in Table 1/column 4 of the same row such that the nucleotide residues encode an amino acid that differs from the amino acid residue referred to in Table 1/column 5 of the same row, or a complement thereof.
2 . The isolated nucleic acid molecule of claim 1 , wherein the amino acid residue at the position referred to in Table 1/column 4 is the amino acid indicated in Table 1/column 6 in the same row.
3 . A vector comprising the nucleic acid molecule of claim 1 .
4 . An isolated host cell, which is transfected with the vector of claim 9 .
5 . The host cell of claim 4 , wherein the expression of said nucleic acid molecule modulates the production of a fine chemical from said cell.
6 . A method for preparing a fine chemical, comprising culturing the cell of claim 4 such that the fine chemical is produced.
7 . The method of claim 6 , wherein the fine chemical is an amino acid.
8 . The method of claim 7 , wherein said amino acid is lysine.
9 . The vector of claim 3 , which is an expression vector.
10 . The host cell of claim 4 , wherein said cell is a microorganism.
11 . The host cell of claim 10 , wherein said cell belongs to the genus Corynebacterium or Brevibacterium.
12 . The host cell of claim 5 , wherein said fine chemical is selected from the group consisting of organic acids, proteinogenic and nonproteinogenic amino acids, purine and pyrimidine bases, nucleosides, nucleotides, lipids, saturated and unsaturated fatty acids, diols, carbohydrates, aromatic compounds, vitamins, cofactors and enzymes.
13 . The method of claim 6 , wherein said cell belongs to the genus Corynebacterium or Brevibacterium.
14 . The method of claim 6 , wherein expression of the nucleic acid molecule from said vector results in modulation of production of said fine chemical.
15 . The method of claim 6 , wherein said fine chemical is selected from the group consisting of organic acids, proteinogenic and nonproteinogenic amino acids, purine and pyrimidine bases, nucleosides, nucleotides, lipids, saturated and unsaturated fatty acids, diols, carbohydrates, aromatic compounds, vitamins, cofactors and enzymes.
16 . A method for producing a fine chemical, comprising culturing a cell whose genomic DNA has been altered by the inclusion of a nucleic acid molecule of claim 1.Join the waitlist — get patent alerts
Track US2007037262A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.